WORK Medical Technology Group LTD closed a private placement of securities on August 18, 2026, raising approximately $2,125,000 in aggregate gross proceeds. The company issued 2,000,000 Class A ordinary shares at $1.00 per share and 50,000 Class B ordinary shares at $2.50 per share to non-U.S. investors under Regulation S exemptions. Following the transaction, outstanding shares totaled 4,416,569 Class A and 51,009 Class B shares. The company intends to use the proceeds for business expansion, working capital, and general corporate purposes. WORK Medical Technology Group LTD operates in the medical technology industry, developing and commercializing medical devices.

WORK Medical Technology Group LTD filed its unaudited financial statements for the six months ended March 31, 2026. The company reported a net loss of $3,461,214, compared to a net loss of $29,425 in the prior year period. Net revenue increased 19.1% to $5.4 million, driven by an 18.1% rise in medical device sales and a 38.0% increase in mask sales. Gross profit declined 33.7% to $1,036,195 as gross margins contracted from 34.4% to 19.1%, primarily due to lower prices under China's volume-based procurement policy. The company completed a public offering raising approximately $17.1 million and acquired the remaining non-controlling interest in Shanghai Saitumofei for $3.22 million. Cash and cash equivalents stood at $3.25 million as of March 31, 2026. WORK Medical Technology Group LTD manufactures and sells medical consumables, including masks and anesthesia devices, through its subsidiaries in China.

WORK Medical Technology Group LTD announced a 1-for-100 reverse stock split of its Class A and Class B ordinary shares, effective June 18, 2026. The consolidation was implemented to meet Nasdaq’s minimum bid price continued listing standards and mitigate delisting risk. Following the split, approximately 2.42 million ordinary shares are issued and outstanding. Additionally, on August 4, 2026, the Company entered into securities purchase agreements for a private placement of up to 2,000,000 Class A ordinary shares at $1.00 per share and 50,000 Class B ordinary shares at $2.50 per share, targeting proceeds of approximately $2,125,000 for business expansion and working capital; however, the closing conditions had not been satisfied as of the filing date. WORK Medical Technology Group LTD operates in the medical device industry, developing and manufacturing Class I and II medical devices and consumables.